Follow the people · Insider
Renee Gaeta
Renee Gaeta files insider transactions with the SEC as a chief financial officer of Outset Medical (OM). We hold 2 disclosed purchases and sales filed since 20 February 2019, 1 of them in the last 90 days.
- Files forOM
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
5 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 June 2025 — 17 August 2026Chief Financial Officer · Outset Medical (OM)4 Form 4 lines · source: SEC Form 4
- Filed 8 August 2022 — 23 June 2026Director · Candel Therapeutics (CADL)5 Form 4 lines · source: SEC Form 4
- Filed 5 February 2024 — 31 May 2024Chief Financial Officer · Shockwave Medical (SWAV)2 Form 4 lines · source: SEC Form 4
- Filed 19 February 2019 — 5 January 2023Director · SeaSpine Holdings (SPNE)16 Form 4 lines · source: SEC Form 4
- Filed 26 June 2020 — 21 May 2021Chief Financial Officer · Establishment Labs Holdings (ESTA)16 Form 4 lines · source: SEC Form 4
Everything they disclosed
43 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 4,543 shares of Outset MedicalSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- was granted 71,630 shares of Outset MedicalSEC Form 429 June 2026Common Stock · traded 26 June 2026 · filed 29 June 2026
- was granted 32,000 shares of Candel Therapeutics (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 23 June 2026 · filed 24 June 2026
- ▼ sold on the open market 17,672 shares of Outset MedicalSEC Form 45 June 2026Common Stock · traded 3 June 2026 · filed 5 June 2026
- was granted 14,240 shares of Candel Therapeutics (a derivative holding)SEC Form 418 June 2025Stock Option (Right to Buy) · traded 17 June 2025 · filed 18 June 2025
- was granted 131,425 shares of Outset MedicalSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- was granted 14,240 shares of Candel Therapeutics (a derivative holding)SEC Form 427 June 2024Stock Option (Right to Buy) · traded 26 June 2024 · filed 27 June 2024
- returned to the issuer 19,890 shares of Shockwave MedicalSEC Form 431 May 2024Common Stock · traded 31 May 2024 · filed 31 May 2024
- was granted 19,890 shares of Shockwave MedicalSEC Form 46 February 2024Common Stock · traded 5 February 2024 · filed 6 February 2024
- was granted 14,240 shares of Candel Therapeutics (a derivative holding)SEC Form 429 June 2023Stock Option (Right to Buy) · traded 28 June 2023 · filed 29 June 2023
- returned to the issuer 36,056 shares of SeaSpine HoldingsSEC Form 49 January 2023Common Stock · traded 5 January 2023 · filed 9 January 2023
- was granted 28,480 shares of Candel Therapeutics (a derivative holding)SEC Form 410 August 2022Stock Option (Right to Buy) · traded 8 August 2022 · filed 10 August 2022
- was granted 15,943 shares of SeaSpine HoldingsSEC Form 43 June 2022Common Stock · traded 1 June 2022 · filed 3 June 2022
- ▼ sold on the open market 2,000 shares of SeaSpine HoldingsSEC Form 415 March 2022Common Stock · traded 14 March 2022 · filed 15 March 2022
- ▼ sold on the open market 2,000 shares of SeaSpine HoldingsSEC Form 416 February 2022Common Stock · traded 14 February 2022 · filed 16 February 2022
- ▼ sold on the open market 2,000 shares of SeaSpine HoldingsSEC Form 410 January 2022Common Stock · traded 10 January 2022 · filed 10 January 2022
- was granted 609 shares of SeaSpine HoldingsSEC Form 42 July 2021Common Stock · traded 30 June 2021 · filed 2 July 2021
- was granted 6,253 shares of SeaSpine HoldingsSEC Form 44 June 2021Common Stock · traded 2 June 2021 · filed 4 June 2021
- exercised options over 6,260 shares of Establishment Labs Holdings (a derivative holding)SEC Form 421 May 2021Stock Option (Right to buy) · traded 20 May 2021 · filed 21 May 2021
- exercised options over 2,840 shares of Establishment Labs Holdings (a derivative holding)SEC Form 421 May 2021Stock Option (Right to buy) · traded 21 May 2021 · filed 21 May 2021
- exercised options over 6,260 shares of Establishment Labs HoldingsSEC Form 421 May 2021Common Shares · traded 20 May 2021 · filed 21 May 2021
- ▼ sold on the open market 6,260 shares of Establishment Labs HoldingsSEC Form 421 May 2021Common Shares · traded 20 May 2021 · filed 21 May 2021
- exercised options over 2,840 shares of Establishment Labs HoldingsSEC Form 421 May 2021Common Shares · traded 21 May 2021 · filed 21 May 2021
- ▼ sold on the open market 694 shares of Establishment Labs HoldingsSEC Form 421 May 2021Common Shares · traded 21 May 2021 · filed 21 May 2021
- ▼ sold on the open market 1,958 shares of Establishment Labs HoldingsSEC Form 421 May 2021Common Shares · traded 21 May 2021 · filed 21 May 2021
- ▼ sold on the open market 188 shares of Establishment Labs HoldingsSEC Form 421 May 2021Common Shares · traded 21 May 2021 · filed 21 May 2021
- exercised options over 100 shares of Establishment Labs HoldingsSEC Form 420 May 2021Common Shares · traded 18 May 2021 · filed 20 May 2021
- ▼ sold on the open market 100 shares of Establishment Labs HoldingsSEC Form 420 May 2021Common Shares · traded 18 May 2021 · filed 20 May 2021
- exercised options over 800 shares of Establishment Labs HoldingsSEC Form 420 May 2021Common Shares · traded 19 May 2021 · filed 20 May 2021
- ▼ sold on the open market 800 shares of Establishment Labs HoldingsSEC Form 420 May 2021Common Shares · traded 19 May 2021 · filed 20 May 2021
- exercised options over 100 shares of Establishment Labs Holdings (a derivative holding)SEC Form 420 May 2021Stock Option (Right to buy) · traded 18 May 2021 · filed 20 May 2021
- exercised options over 800 shares of Establishment Labs Holdings (a derivative holding)SEC Form 420 May 2021Stock Option (Right to buy) · traded 19 May 2021 · filed 20 May 2021
- was granted 718 shares of SeaSpine HoldingsSEC Form 41 April 2021Common Stock · traded 31 March 2021 · filed 1 April 2021
- ▼ sold on the open market 2,920 shares of SeaSpine HoldingsSEC Form 48 March 2021Common Stock · traded 8 March 2021 · filed 8 March 2021
- ▼ sold on the open market 3,000 shares of SeaSpine HoldingsSEC Form 423 February 2021Common Stock · traded 22 February 2021 · filed 23 February 2021
- was granted 12,401 shares of Establishment Labs Holdings (a derivative holding)SEC Form 417 February 2021Stock Option (Right to buy) · traded 12 February 2021 · filed 17 February 2021
- was granted 716 shares of SeaSpine HoldingsSEC Form 44 January 2021Common Stock · traded 31 December 2020 · filed 4 January 2021
- was granted 874 shares of SeaSpine HoldingsSEC Form 41 October 2020Common Stock · traded 30 September 2020 · filed 1 October 2020
- was granted 1,193 shares of SeaSpine HoldingsSEC Form 42 July 2020Common Stock · traded 30 June 2020 · filed 2 July 2020
- was granted 35,000 shares of Establishment Labs Holdings (a derivative holding)SEC Form 430 June 2020Stock Option (Right to buy) · traded 26 June 2020 · filed 30 June 2020
- was granted 8,488 shares of SeaSpine HoldingsSEC Form 45 June 2020Common Stock · traded 3 June 2020 · filed 5 June 2020
- was granted 7,262 shares of SeaSpine HoldingsSEC Form 431 May 2019Common Stock · traded 29 May 2019 · filed 31 May 2019
- was granted 5,920 shares of SeaSpine HoldingsSEC Form 420 February 2019Common Stock · traded 19 February 2019 · filed 20 February 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.